Foritinib in advanced ROS1-rearranged non-small-cell lung cancer in China: a multicentre, open-label, single-arm, phase 2 study
Article in The Lancet Respiratory Medicine (July 2024)
The most recent citing publications are shown below. View all 53 publications that cite this research output on Dimensions.
Article in The Lancet Respiratory Medicine (July 2024)
Article in Biomedicines (June 2024)
Article in Cancer Drug Resistance (May 2024)